Takeda Development Center Americas, Inc. recalls
Every recall we track for Takeda Development Center Americas, Inc. — 2 in all, all from 2018 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
2 recalls since 2017.
All FDA recall records for Takeda Development Center Americas, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 2 | 0 | 2 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled Takeda Development Center Americas, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Takeda Development Center Americas, Inc. recalls
2 shown- Lower riskDrug
Takeda Development Center Americas, Inc. recalls AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Rockville
Takeda recalls AMITIZA (lubiprostone) 8 mcg capsules due to elevated impurities in stability testing. This may affect safety for patients using prescription medication.
TakedaNov 6, 2018 - Lower riskDrug
Takeda Development Center Americas, Inc. recalls Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle,
Takeda recalls 15 mg/1000 mg Actoplus met XR tablets with missing laser holes on metformin core. These tablets may not release medication properly. Check NDC 64764-510-30, lots A26004 (exp Apr 2020) and A26443/A26444 (exp Sep 2020).
TakedaSep 10, 2018
Takeda Development Center Americas, Inc. recall questions
How many recalls has Takeda Development Center Americas, Inc. had?
2 recalls from Takeda Development Center Americas, Inc. are on record with U.S. safety agencies, from 2018.
What is the most recent Takeda Development Center Americas, Inc. recall?
Takeda Development Center Americas, Inc. recalls AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Rockville, dated Nov 6, 2018. Every Takeda Development Center Americas, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Takeda Development Center Americas, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Takeda Development Center Americas, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.